NEW YORK, July 16, 2015 /PRNewswire/ -- Faruqi &
Faruqi, LLP, a leading national securities law firm, is
investigating potential wrongdoing at Keryx Biopharmaceuticals,
Inc. ("Keryx " or the "Company") (Nasdaq: KERX).
The investigation focuses on whether the Company and its
officers breached their fiduciary duties with respect to the
Keryx's corporate governance controls.
Request more information now by clicking here:
www.faruqilaw.com/KERX. There is no cost or obligation to
you.
Take Action
If you currently own Keryx stock and have continuously owned
Keryx stock and would like to discuss your legal rights, please
visit www.faruqilaw.com/KERX. You can also contact us by calling
Nadeem Faruqi toll free at (212)
983-9330 or by sending an e-mail to nfaruqi@faruqilaw.com. Faruqi
& Faruqi, LLP also encourages anyone with information regarding
Keryx's conduct to contact the firm, including whistleblowers,
former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this
advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or
predict a similar outcome with respect to any future matter.
We welcome the opportunity to discuss your particular case.
All communications will be treated in a confidential manner.
FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Nadeem Faruqi
nfaruqi@faruqilaw.com
Telephone: (212) 983-9330
Logo -
http://photos.prnewswire.com/prnh/20120119/MM38856LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/faruqi--faruqi-llp-is-investigating-keryx-biopharmaceuticals-inc-kerx-on-behalf-of-its-shareholders-300114724.html
SOURCE Faruqi & Faruqi, LLP